CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving 177Lu-PSMA-617
DOI 10.1055/s-0039-1683558
Bibliografische Angaben
Nachweis in CareLit
Autor:innenK Kessel, A Breuer, R Seifert, M Schäfers, M Bögemann, K Rahbar
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe02/2019
Jahrgang / SeitenJg. 58
Kernaussage aus der Literatur
Abstract-Vorschau
Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving 177Lu-PSMA-617
Zitieren
Zitierempfehlung
K Kessel, A Breuer, R Seifert, M Schäfers, M Bögemann, K Rahbar (2019) Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving 177Lu-PSMA-617. Nuklearmedizin - NuclearMedicine, 58 (02). https://doi.org/10.1055/s-0039-1683558
Mit CareLit weiterarbeiten